A carregar...
Split high‐dose oral levothyroxine treatment as a successful therapy option in myxedema coma
High‐dose intravenous thyroxine (T4) is the preferable treatment for myxedema coma. We describe the clinical course of a 69‐year‐old man who presented with myxedema coma and received oral levothyroxine (LT4) therapy (1 mg) in a split dose. This suggests split high‐dose oral LT4 as a therapeutic opti...
Na minha lista:
| Publicado no: | Clin Case Rep |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5628197/ https://ncbi.nlm.nih.gov/pubmed/29026577 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.1131 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|